vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Tri Pointe Homes, Inc. (TPH). Click either name above to swap in a different company.

Tri Pointe Homes, Inc. is the larger business by last-quarter revenue ($972.6M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). Tri Pointe Homes, Inc. runs the higher net margin — 6.2% vs -10.1%, a 16.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -22.4%). Tri Pointe Homes, Inc. produced more free cash flow last quarter ($213.2M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 1.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Tri Pointe Homes, Inc. is a home construction company headquartered in Incline Village, Nevada. It also offers financing and insurance services to homebuyers. It operates in Arizona, California, Nevada, Washington, Colorado, Texas, the District of Columbia, Maryland, North Carolina, South Carolina, and Virginia. The company is the 18th largest home construction company in the United States based on the number of homes closed.

CLOV vs TPH — Head-to-Head

Bigger by revenue
TPH
TPH
2.0× larger
TPH
$972.6M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+67.2% gap
CLOV
44.7%
-22.4%
TPH
Higher net margin
TPH
TPH
16.3% more per $
TPH
6.2%
-10.1%
CLOV
More free cash flow
TPH
TPH
$282.1M more FCF
TPH
$213.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
1.8%
TPH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
TPH
TPH
Revenue
$487.7M
$972.6M
Net Profit
$-49.3M
$60.2M
Gross Margin
Operating Margin
-10.1%
8.1%
Net Margin
-10.1%
6.2%
Revenue YoY
44.7%
-22.4%
Net Profit YoY
-123.2%
-53.4%
EPS (diluted)
$0.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TPH
TPH
Q4 25
$487.7M
$972.6M
Q3 25
$496.6M
$854.7M
Q2 25
$477.6M
$902.4M
Q1 25
$462.3M
$740.9M
Q4 24
$337.0M
$1.3B
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
$1.2B
Q1 24
$346.9M
$939.4M
Net Profit
CLOV
CLOV
TPH
TPH
Q4 25
$-49.3M
$60.2M
Q3 25
$-24.4M
$56.1M
Q2 25
$-10.6M
$60.7M
Q1 25
$-1.3M
$64.0M
Q4 24
$-22.1M
$129.2M
Q3 24
$-9.2M
$111.8M
Q2 24
$7.4M
$118.0M
Q1 24
$-19.2M
$99.1M
Gross Margin
CLOV
CLOV
TPH
TPH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
TPH
TPH
Q4 25
-10.1%
8.1%
Q3 25
-4.9%
8.1%
Q2 25
-2.2%
8.5%
Q1 25
-0.3%
10.4%
Q4 24
-6.4%
13.4%
Q3 24
-2.7%
12.6%
Q2 24
2.0%
12.9%
Q1 24
-6.5%
12.3%
Net Margin
CLOV
CLOV
TPH
TPH
Q4 25
-10.1%
6.2%
Q3 25
-4.9%
6.6%
Q2 25
-2.2%
6.7%
Q1 25
-0.3%
8.6%
Q4 24
-6.6%
10.3%
Q3 24
-2.8%
9.8%
Q2 24
2.1%
10.2%
Q1 24
-5.5%
10.5%
EPS (diluted)
CLOV
CLOV
TPH
TPH
Q4 25
$0.70
Q3 25
$0.64
Q2 25
$0.68
Q1 25
$0.70
Q4 24
$1.37
Q3 24
$1.18
Q2 24
$1.25
Q1 24
$1.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TPH
TPH
Cash + ST InvestmentsLiquidity on hand
$78.3M
$982.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$3.3B
Total Assets
$541.0M
$5.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TPH
TPH
Q4 25
$78.3M
$982.8M
Q3 25
$792.0M
Q2 25
$622.6M
Q1 25
$812.9M
Q4 24
$194.5M
$970.0M
Q3 24
$288.0M
$676.0M
Q2 24
$254.8M
$492.9M
Q1 24
$208.3M
$944.0M
Total Debt
CLOV
CLOV
TPH
TPH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$646.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
TPH
TPH
Q4 25
$308.7M
$3.3B
Q3 25
$340.9M
$3.3B
Q2 25
$344.2M
$3.3B
Q1 25
$336.1M
$3.3B
Q4 24
$341.1M
$3.3B
Q3 24
$342.2M
$3.2B
Q2 24
$324.9M
$3.1B
Q1 24
$292.5M
$3.0B
Total Assets
CLOV
CLOV
TPH
TPH
Q4 25
$541.0M
$5.0B
Q3 25
$559.7M
$5.0B
Q2 25
$575.0M
$4.8B
Q1 25
$583.7M
$4.8B
Q4 24
$580.7M
$4.9B
Q3 24
$653.0M
$4.8B
Q2 24
$674.2M
$4.6B
Q1 24
$671.8M
$5.0B
Debt / Equity
CLOV
CLOV
TPH
TPH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TPH
TPH
Operating Cash FlowLast quarter
$-66.9M
$221.0M
Free Cash FlowOCF − Capex
$-69.0M
$213.2M
FCF MarginFCF / Revenue
-14.1%
21.9%
Capex IntensityCapex / Revenue
0.4%
0.8%
Cash ConversionOCF / Net Profit
3.67×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$128.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TPH
TPH
Q4 25
$-66.9M
$221.0M
Q3 25
$12.1M
$45.9M
Q2 25
$5.4M
$-74.3M
Q1 25
$-16.3M
$-31.2M
Q4 24
$34.8M
$360.3M
Q3 24
$50.0M
$167.9M
Q2 24
$44.8M
$23.1M
Q1 24
$25.9M
$144.7M
Free Cash Flow
CLOV
CLOV
TPH
TPH
Q4 25
$-69.0M
$213.2M
Q3 25
$11.4M
$39.1M
Q2 25
$4.8M
$-84.5M
Q1 25
$-16.5M
$-39.3M
Q4 24
$33.3M
$355.9M
Q3 24
$49.6M
$161.5M
Q2 24
$44.4M
$17.0M
Q1 24
$25.5M
$138.3M
FCF Margin
CLOV
CLOV
TPH
TPH
Q4 25
-14.1%
21.9%
Q3 25
2.3%
4.6%
Q2 25
1.0%
-9.4%
Q1 25
-3.6%
-5.3%
Q4 24
9.9%
28.4%
Q3 24
15.0%
14.1%
Q2 24
12.5%
1.5%
Q1 24
7.3%
14.7%
Capex Intensity
CLOV
CLOV
TPH
TPH
Q4 25
0.4%
0.8%
Q3 25
0.1%
0.8%
Q2 25
0.1%
1.1%
Q1 25
0.0%
1.1%
Q4 24
0.5%
0.3%
Q3 24
0.1%
0.6%
Q2 24
0.1%
0.5%
Q1 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
TPH
TPH
Q4 25
3.67×
Q3 25
0.82×
Q2 25
-1.22×
Q1 25
-0.49×
Q4 24
2.79×
Q3 24
1.50×
Q2 24
6.04×
0.20×
Q1 24
1.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TPH
TPH

West$547.8M56%
Central$245.1M25%
East$161.8M17%
Financial Services Segment$18.0M2%
Land$7.9M1%

Related Comparisons